Loading data
SPCENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.54 m USD | 7.04 m USD | 6.8 m USD | 2.31 m USD | 3.29 m USD |
| Cost of revenue | 72.77 m USD | 90.02 m USD | 50.54 m USD | 1.91 m USD | 272 k USD |
| Research and development expense | 80.47 m USD | 152.68 m USD | 295.14 m USD | 314.17 m USD | 144.22 m USD |
| Selling, general and administrative expense | 117.17 m USD | 125.5 m USD | 174.86 m USD | 175.12 m USD | 166.81 m USD |
| Operating profit | -285.34 m USD | -376.63 m USD | -531.51 m USD | -499.98 m USD | -319.54 m USD |
| Interest expense | — | — | 12.87 m USD | 12.13 m USD | 25 k USD |
| Profit before tax | -278.86 m USD | -346.67 m USD | -501.88 m USD | -499.55 m USD | -352.82 m USD |
| Income tax expense | 52 k USD | 74 k USD | 453 k USD | 598 k USD | 79 k USD |
| Net income (reported basis) | -278.91 k USD | -346.74 k USD | -502.34 k USD | -500.15 k USD | -352.9 k USD |
| Net income attributable to common shareholders | -278.91 m USD | -346.74 m USD | -502.34 m USD | -500.15 m USD | -352.9 m USD |
| Basic earnings per share | -5.44 USD/share | -13.89 USD/share | -29.79 USD/share | -1.89 USD/share | -1.43 USD/share |
| Diluted earnings per share | -5.44 USD/share | -13.89 USD/share | -29.79 USD/share | -1.89 USD/share | -1.43 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.